New search | Conferencedetail
mail
Print view
 
 

7th Obesity and NASH Summit

Evvnt Promotion / evvnt
Archive
-
27.11.2023 - 29.11.2023  The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, Massachusetts, USA
Time: 9:25 am - 4:00 pm
 
Conference themes
Eli Lilly's 'triple G' drug retatrutide has galvanized the metabolic field to boost investment in the game-changing obesity drug revolution. With up to 24% weight loss, a new record for the obesity field has been set and the time to get ahead of the curve is now.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/1972456-3?pid=4832

Speakers: Ana Paula Cancino, Global Executive Medical Director, Obesity, Amgen, Brian Finan, Vice President, Obesity, Novo Nordisk, Cindy Hartsfield, Director, Medical Affairs, 89bio, and more.
 

Enquiries and Registration:

https://go.evvnt.com/1972456-2?pid=4832
Ms. Rona Perry
 
Categories
General Medicine
Languages
English
Congress fees
Drug Developer Conference + Workshop Day Ticket: USD 4946.00, Drug Developer Conference Only: USD 2999.00, Solution Provider Conference + Workshop Day: USD 6046.00, Solution Provider Conference Only: USD 3799.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

European Public Health Association (EUPHA)Ärztekammer für WienSwiss Tropical and Public Health InstituteHilfswerk AustriaAlumni Club Medizinische Universität WienCharité International AcademyCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarionewTree